SCHEMBL19796052

SCHEMBL19796052

Cc1nc(Cl)nc(Cl)c1C(=O)O

nearest known ligand 0.52

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.52
MAPK1 P28482 1/20 0.52
SMN1; SMN2 Q16637 1/20 0.52
TSHR P16473 2/20 0.39
HPGD P15428 1/20 0.39
PDE10A Q9Y233 2/20 0.39
KMT2A Q03164 4/20 0.38
MEN1 O00255 2/20 0.38
FABP3 P05413 1/20 0.37
FABP4 P15090 1/20 0.37
POLB P06746 1/20 0.37
DHODH Q02127 2/20 0.33
HTT P42858 2/20 0.33
TP53 P04637 1/20 0.33
HSD17B10 Q99714 1/20 0.33
NOTUM Q6P988 1/20 0.33
KDM4E B2RXH2 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3543372 0.89 ALDH1A1 (0.47) ALDH1A1MAPK1SMN1; SMN2TSHRHPGD
SCHEMBL1989330 0.84 ALDH1A1 (0.50) ALDH1A1MAPK1SMN1; SMN2TSHRHPGD
SCHEMBL8541716 0.83 ALDH1A1 (0.38) ALDH1A1MAPK1SMN1; SMN2TSHRHPGD
Hydrochloric Acid SCHEMBL10581422 0.81 ALDH1A1 (0.48) ALDH1A1MAPK1SMN1; SMN2TSHRHPGD
SCHEMBL19796043 0.81 POLB (0.53) ALDH1A1MAPK1SMN1; SMN2TSHRHPGD
SCHEMBL12563886 0.78 ALDH1A1 (0.35) ALDH1A1MAPK1SMN1; SMN2POLB
SCHEMBL62649 0.78 KMT2A (0.41) ALDH1A1SMN1; SMN2HPGDKMT2AMEN1
SCHEMBL31368629 0.78 KMT2A (0.41) ALDH1A1SMN1; SMN2HPGDKMT2AMEN1
SCHEMBL31368630 0.78 KMT2A (0.41) ALDH1A1SMN1; SMN2HPGDKMT2AMEN1
SCHEMBL21713101 0.76 FABP3 (0.40) ALDH1A1MAPK1SMN1; SMN2TSHRHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023104165-A1 PYRIDINE[4,3-D]PYRIMIDINE COMPOUND AS TLR7/8 AGONIST 上海维申医药有限公司 2023-06-15 WO disclosed
US-20180022710-A1 ISOTOPOLOGUES OF 2-(TERT-BUTYLAMINO)-4-((1R,3R,4R)-3-HYDROXY-4-METHYLCYCLOHEXYLAMINO)-PYRIMIDINE-5-CARBOXAMIDE SIGNAL PHARMACEUTICALS, LLC 2018-01-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180022710-A1 ISOTOPOLOGUES OF 2-(TERT-BUTYLAMINO)-4-((1R,3R,4R)-3-HYDROXY-4-METHYLCYCLOHEXYLAMINO)-PYRIMIDINE-5-CARBOXAMIDE H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, TERT, NPY4R ALDH1A1 1028/4885MAPK1 4281/4885SMN1; SMN2 1488/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.